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Abstract The Mesenchymal-to-Epithelial Transition (MET) has been recognized as a crucial step for successful reprogramming
of fibroblasts to induced pluripotent stem cells (iPSCs). Thus, it has been demonstrated, that the efficiency of reprogramming
can be enhanced by promoting an epithelial expression program in cells, with a concomitant repression of key mesenchymal
genes. However, a detailed characterization of the epithelial transition associated with the acquisition of a pluripotent
phenotype is still lacking to this date.
Here, we integrate a panel of morphological approaches with gene expression analyses to visualize the dynamics of episomal
reprogramming of human fibroblasts to iPSCs. We provide the first ultrastructural analysis of human fibroblasts at various
stages of episomal iPSC reprogramming, as well as the first real-time live cell visualization of a MET occurring during
reprogramming. The results indicate that the MET manifests itself approximately 6–12 days after electroporation, in synchrony
with the upregulation of early pluripotency markers, and resembles a reversal of the Epithelial-to-Mesenchymal Transition
(EMT) which takes place during mammalian gastrulation.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
In 2006, Shinya Yamanaka 's group made the groundbreaking
discovery that somatic cells could be reprogrammed to
induced pluripotent stem cells (iPSCs) by retroviral
overexpression of the four embryonic transcription factors
OCT4, C-MYC, SOX2 and KLF4 (abbreviated OMSK) (Takahashi
and Yamanaka, 2006). This paved the road for a new era of
stem cell research involving the generation of
patient-specific stem cells and disease models, and a vision
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OCT4 + C-MYC + SOX2 + KLF4; EMT, Epithelial-to-Mesenchymal Transition; MET, Mesenchymal-to-Epithelial Transition; NHDFs, Normal
Human Dermal Fibroblasts; qPCR, quantitative PCR; GFP, green fluorescent protein.
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of performing autologous transplantation for various degen-
erative diseases in the future. The fact that self-renewing
pluripotent stem cells could be generated from almost any
type of differentiated cell, provided researchers with an
inexhaustible pool of pluripotent stem cells, and
circumvented many of the ethical concerns associated with
human embryonic stem cells (ESCs). Thus, iPSCs are
increasingly applied as a complementary strategy to ESCs
in stem cell research today.
Since Yamanaka's remarkable findings, much effort has
been invested in revealing the pathways leading to reacti-
vation of the endogenous pluripotency apparatus in differ-
entiated cells, and in identifying factors which regulate this
process. In 2010 it was reported that during the course of
iPSC reprogramming, mouse embryonic fibroblasts (MEFs)
transition from a mesenchymal phenotype into an epithelial
phenotype, before reaching the pluripotent state (Li et al.,
2010; Samavarchi-Tehrani et al., 2010). Transitions between
epithelial and mesenchymal states are well known from
embryonic development, for example during gastrulation,
when epithelial cells from the pluripotent epithelial epiblast
ingress through the primitive streak to form the mesodermal
and endodermal lineages, and during neurulation when
neural crest cells delaminate from the neural epithelium at
the hinge point of the neural groove (Kalluri and Weinberg,
2009). Morphologically, these examples of so-called
Epithelial-to-Mesenchymal Transitions (EMTs) are character-
ized by a switch from an epithelial columnar cell type with
apical–basal polarity defined by the anchorage to neighbor-
ing cells via tight junctions, adherens junctions and
desmosomes, towards a spindle-shaped and solitary cell
type with migratory protrusions and invasive capacity
(Ferrer-Vaquer et al., 2010). Crucially for this to occur, the
Actin cytoskeleton must rearrange from a terminal web into
stress fibers. At the molecular level, EMT involves a
coordinated downregulation of epithelial markers such as
E-cadherin, Zo-1 and Cytokeratin and upregulation of
mesenchymal markers such as Vimentin, Snai1/2, ZEB1
and N-Cadherin (Zeisberg and Neilson, 2009). Mesenchymal-
to-Epithelial Transition (MET) represents the reverse process of
EMT and also occurs during embryonic development, for
example when mesenchymal cells, which have ingressed
through the anterior primitive streak, form the foregut
endoderm epithelium (Ferrer-Vaquer et al., 2010).
The MET occurring during reprogramming appears to be
an important step towards the full dedifferentiation of
fibroblasts to iPSCs (Li et al., 2010; Samavarchi-Tehrani et
al., 2010; Liao et al., 2011a; Subramanyam et al., 2011a;
Shu and Pei, 2014). Li et al. showed that the transcription
factors OMSK work in concert during reprogramming of MEFs
to suppress EMT drivers and promote expression of epithelial
markers. In addition, they demonstrated that blocking or
reversing the MET during reprogramming resulted in signif-
icant reduction in the number of emerging pluripotent
colonies (Li et al., 2010). Accordingly, the Wrana lab divided
the reprogramming of MEFs into three phases termed
Initiation, Maturation and Stabilization, based on gene
expression profiling, and reported MET as a hallmark of the
Initiation phase between days 0 and 5 post-transduction
(Samavarchi-Tehrani et al., 2010). Following up on these
findings, several groups have identified microRNAs (Lee et
al., 2013; Wang et al., 2013; Liao et al., 2011b; Li et al.,
2011), genes (Chen et al., 2012; Takahashi et al., 2014;
Sakurai et al., 2014) and epigenetic modifiers (Hu et al.,
2014; Onder et al., 2012; Liang et al., 2012) which enhance
reprogramming by promoting MET, either directly by
stimulating the expression of epithelial proteins, or indirectly
by inhibiting EMT inducing signals. Thus, extensive research on
cell signaling and gene regulation points towards an impor-
tant, and potentially causal, link between cell epithelializa-
tion and gain of pluripotent characteristics. However,
surprisingly few iPSC studies have focused on characterizing
the morphogenesis of solitary somatic cells turning into a
pluripotent epithelium. In fact, to our knowledge there has
been no ultrastructural report on the dynamics of iPSC
reprogramming to date. How exactly do changes in gene
expression during reprogramming correlate with changes
in cell–cell organization, cytoskeletal architecture, and
secretory pathway components? Can parallels be drawn to
the pluripotent epithelium of the mammalian epiblast?
In other words, does transcription factor reprogramming
involve the same dynamic patterns of intercellular contact
and communication as those seen during embryonic develop-
ment? These are the questions we seek to elucidate in this
study. To this end, we present an ultrastructural character-
ization of human fibroblasts undergoing reprogramming to
iPSCs, and compare this to the ultrastructure of porcine
gastrulation.
Materials and methods
Cell culture
Adult Normal Human Dermal Fibroblasts (NHDFs) were pur-
chased from Lonza (Clonetics™ Human Fibroblast Cell Systems,
CC-2511). Cells were seeded in the Corning T175 flasks (Sigma,
CLS431079) coated with 0.1% gelatin (Sigma-Aldrich, G2500)
and cultured in Dulbecco's modified Eagle's medium with
4500 mg/L glucose (DMEM-AQmedia™, Sigma-Aldrich, D0819)
supplemented with 10% FBS (GIBCO, 10270-098) and 100 μg/mL
penicillin/streptomycin (Sigma-Aldrich, P0781) at 37 °C in a
humidified atmosphere of 5% CO2 (fibroblast conditions).
Medium was replaced every other day, and cells were
enzymatically passaged with Trypsin–EDTA (Sigma-Aldrich,
T3924) when reaching 90% confluence. iPSCs were kept in 6
well plates coated with ESC-qualified BD Matrigel™ (BD
Biosciences, 354277) and cultured in mTeSR™1 (Stemcell
Technologies, 05850) at 37 °C in a humidified atmosphere of
5% CO2, 5% O2 and 90% N2 (stem cell conditions). Medium was
replaced every other day, and colonies were manually
passaged with an insulin needle (Myjector U-100 0.5 mL
27Gx1/2″, Terumo, BS05M2713) every 5–7 days.
Episomal plasmids, electroporation
and reprogramming
Episomal plasmids pCXLE-hUL, pCXLE-hSK and pCXLE-hOCT3/
4-shp53-F were published by Okita et al. (2011) and modified
from Niwa et al. (1991). All plasmids were purchased from
Addgene (27080, 27078, 27077) and purifiedwith the Purelink®
HiPure Plasmid Maxiprep kit (Invitrogen, K2100-06). For each
replicate, a total of 1 μg DNA (plasmids mixed 1:1:1) was
electroporated into 100,000 NHDF P5-7 in suspension using the
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Neon™ Transfection System (Invitrogen, MPK5000) with a
protocol of 2 pulses at 1200 V and pulse width of 20 ms
(efficiency of electroporation: 65–70%, n = 3). Electroporated
cells were seeded in 6 well plates (105 cells/well) coated with
0.1% gelatin and maintained under fibroblast conditions until
day 6 post-electroporation when they were transferred to stem
cell conditions (80,000 cells/well). On days 20–24, iPSCs were
manually picked.
Cells were collected for analyses on days 0, 6, 9, 12 and
18 of reprogramming as well as after passaging of iPSC
colonies.
Vimentin promoter-GFP cell line
The human Vimentin promoter-EGFP construct is described
in Bindels et al. (2006), Gilles et al. (1999) and Gilles et al.
(2003) and was kindly provided by Dr. Christine Gilles,
Laboratory of Developmental and Tumor Biology, Tour de
Pathologie, B23, 4000 Liège, Belgium. NHDFs were
electroporated with the Vimentin promoter-EGFP construct
using the settings described in the Episomal plasmids,
electroporation and reprogramming section followed by a
14 day selection with 500 μg/mL G418. Then, fibroblasts
were reprogrammed according to the Episomal plasmids,
electroporation and reprogramming section, and used for
real time non-invasive imaging as described in the Real-time
non-invasive imaging section. Additionally, transfected
fibroblasts were enriched by FACS after the G418 selection
to ensure a starting population with a homogenous GFP
signal. This population was reprogrammed according to the
Episomal plasmids, electroporation and reprogramming
section and used for immunocytochemistry.
RNA isolation and quantitative PCR (qPCR)
Cells were detached with trypsin–EDTA and RNA was
isolated using the RNeasy Micro Plus kit (Qiagen, 74034).
1 μg of purified RNA was reverse transcribed into cDNA using
the RevertAid First Strand cDNA Synthesis kit (Thermo
Scientific, K1622). Comparative real-time qPCR was per-
formed on a Roche Lightcycler using SYBR Green I Master Mix
(Roche, 04887352001). All primers were previously pub-
lished and verified by melting curve analysis and gel
electrophoresis. Sequences and references are listed in
Supplementary Table S2. Data analysis was performed
according to the ΔΔCt method using ACTB as endogenous
control, and values from NHDFs at day 0 of reprogramming
were used as a calibrator for relative quantification. The
results are presented as mean ± S.D. of three independent
experiments.
Immunofluorescence
Cells were seeded on Thermo Fisher Scientific Lab-Tek
chamber slides (Sigma-Aldrich, C6932) coated with 0.1%
gelatin or BD Matrigel™. Cells were fixed in 4% formaldehyde
in PBS for 10 min, washed with PBS and permeabilized with
1% Triton X-100 (Merck, 1086431000) for 15 min. Blocking
was performed with 10% normal donkey serum (Millipore,
S30) in 1% BSA/PBS (Sigma-Aldrich, A7906) for 30 min at
room temperature followed by incubation with primary
antibodies in 1% BSA/PBS at 4 °C overnight. The next day,
cells were washed with PBS, incubated with secondary
antibodies for 1 h at room temperature and washed in
PBS again before counterstaining with 1 μg/mL Hoechst
(Life Technologies, H3570) for 10 min at room temperature.
Coverslips (24 × 50 × 0.16 mm, Hounisen, 0422.2450) were
then mounted with fluorescent mounting medium (DAKO,
S3023). Antibodies and concentrations are listed in Supple-
mentary Table S3.
Images were obtained with a Leica TCS SP5 II inverted
confocal laser-scanning microscope with a UV laser, an Argon
laser and a HeNe laser, and a freely tunable AOBS beam
splitter. Acquisition was performed with a 40× objective
(Leica PL FLUOTAR, OIL, NA = 1.00) at a pinhole size of 0.7
airy units. Pictures were post-processed using LAS AF Lite
software and Adobe Photoshop CS4.0.
Transmission electron microscopy (TEM)
Cells were seeded on 13 mm Thermanox Plastic Coverslips
(NUNC, 174950) coated with 0.1% gelatin or BD Matrigel™
and cultured as described in the Cell culture section. On the
day of fixation, cells were washed twice in PBS and fixed in
3% glutaraldehyde (Merck, 1042390250) in 0.1 M
Na-phosphate buffer for 1 h. Coverslips were cut into pieces
of approximately 2 mm × 5 mm and embedded in 4% LB-agar
at 45 °C (Sigma-Aldrich, L2897). Specimens were then
washed twice in 0.1 M Na-phosphate buffer, postfixed in
1% OsO4 in 0.1 M Na-phosphate buffer for 1 h at room
temperature followed by washing twice in 0.1 M
Na-phosphate buffer and distilled water, respectively.
Samples were dehydrated in a series of ascending ethanol
concentrations (50% EtOH for 10 min, 70% EtOH for 10 min,
96% EtOH for 10 min, 99% EtOH for 3 × 20 min) followed by
washing with propylene oxide (Merck, 8070271000) for
2 × 10 min. Samples were embedded in Epon (812 Resin,
TAAB T031) using propylene oxide as an intermedium and
polymerized for 24 h at 60 °C. Semi-thin sections of 2 μm
were cut with glass knives (LKB Bromma 7800, Leica
Microsystems) on an ultramicrotome (Reichert Ultracut S,
Leica, Microsystems) and stained with 1% toluidine blue O
(Millipore 1159300025). Ultra-thin sections (70 nm) were
sectioned with a diamond knife (Jumdi, 2 mm) on an
ultramicrotome (Reichert Ultracut UCT, Leica) and stained
with 2% uranyl acetate (Polyscience, 21447) and lead citrate
(Reynold, 1963). Sections were collected on 150 mesh
copper grids (Gilder, G150-C3) coated with a parlodion/
amyl acetate film (EMS) and imaged with a Philips CM100
transmission electron microscope equipped with a Morada
camera. Preparation of the porcine embryonic disc for
transmission electron microscopy was described in Hall et
al. (2010) and Wolf et al. (2011). For each time point, 2–5
replicates were processed.
Scanning electron microscopy (SEM)
Cells were cultured, fixed and dehydrated in EtOH as
described in the Immunofluorescence section, with excep-
tion of the agar embedding step. Coverslips were cut into
pieces of approximately 0.5 cm × 0.5 cm and critical point
dried (Electron Microscopy Sciences, EMS850) before
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mounting on carbon conductive tabs on aluminium stubs and
sputter coating with 5–30 nm gold/palladium (Quorum
Technologies, SC7640). Micrographs were obtained with a
FEI Quanta 200 Scanning electron microscope at an acceler-
ating voltage of 3–10 kV and images were processed in
Adobe Photoshop CS4.0. For each time point, 3 replicates
were processed.
Real-time non-invasive imaging
Human Vimentin-promoter-EGFP fibroblasts undergoing
reprogramming to iPSC were placed in a Nikon Biostation
IM Version 2.21 on day 6 after electroporation. Phase
contrast and FITC images were captured every 15 min over
a 10 day interval (days 6–15 of reprogramming).
Results
Human fibroblasts form an epithelium within the
first 12 days of episomal reprogramming
Reprogramming of fibroblasts to iPSCs involves profound
changes in cell shape and behavior, ultimately resulting in
the morphogenesis of solitary mesenchymal cells into
colonies of tightly adhering epithelial cells. In order to
unravel the dynamics of this process at the ultrastructural
level, NHDFs were electroporated with non-integrating
episomal plasmids encoding OCT4, SOX2, KLF4, L-MYC,
LIN28 and a short hairpin targeting P53, and cultured under
fibroblast conditions the first week of reprogramming. Then,
cells were passaged to stem cell conditions and cultured for
another 14–18 days before manual picking and clonal
expansion (Fig. 1A). This culturing procedure was based on
the protocol for episomal reprogramming published by
Yamanaka and group in 2011 (Okita et al., 2011), and
resulted in a reprogramming efficiency of approximately
0.2% (n = 15, see Table 1). In addition, we tried to culture
transfected fibroblasts under stem cell conditions from day 1
post-electroporation, thus omitting the fibroblast culture
period and the trypsinization step on day 6. However, under
these stem cell conditions, no iPSC colonies emerged within
30 days (n = 3, results not shown).
SEM revealed that prior to reprogramming NHDFs were
elongated and flattened with an average length of approx-
imately 100 μm. The fibroblasts contained large nucleoli and
a prominent perinuclear endoplasmic reticulum (ER), and
they presented lamellipodia and filopodia characteristic of
migratory cells (Fig. 1B, NHDF). At D6, subpopulations of
smaller and more compact cells were found among the
fibroblasts. These cells had fewer migratory protrusions and
some of them showed a sporadic distribution of microvilli on
their surface (Fig. 1B, D6). At D12, dense and round iPSC-like
colonies were found nesting in the surrounding sheet of
fibroblasts. Cells in these colonies varied greatly in size and
surface structure, displaying diameters ranging from 5 to
30 μm and various degrees of microvilli density (Fig. 1B,
D12). Finally, on D18, colonies had increased their diameter
three to four-fold, and cells appeared more uniform in size
than on day 12 (Fig. 1B, D18). Overall, the scanning electron
microscopy indicated that NHDFs obtained epithelial char-
acteristics during the first 12 days of episomal
reprogramming, after which colonies matured into a more
homogenous population of epithelial cells.
The SEM observations were elaborated by TEM of cells at
five different stages of reprogramming (Fig. 2). Cross sections
of NHDFs at D0 confirmed that prior to reprogramming the
fibroblasts displayed a smooth surface without microvilli and
intercellular junctions (Fig. 2, D0B–C). The cytoplasm was
dominated by intermediate filaments and a prominent rough
ER (Fig. 2, D0E). This phenotype was retained up to D6, when
horizontal sections revealed well developed Golgi stacks
(Fig. 2, D6E). A few cells displayed a sparse and random
distribution of microvilli on their surface (Fig. 2, D6B),
indicating the potential initiation of a MET. At D9, some cells
had assumed a more rounded shape with a higher nuclear:
cytoplasmic ratio and fewer migratory protrusions (Fig. 2,
D9A). In some cases, the plasma membranes of adjacent cells
carried microvilli and were closely apposed, but no signs of
intercellular junctions were found (Fig. 2, D9B–C). The
cytoplasmic content primarily consisted of free polyribosomes
and mitochondria, whereas organelles of the secretory
pathway such as ER and Golgi complexes were no longer
present (Fig. 2, D9E). At D12, some of the cells in iPSC-like
colonies had acquired a columnar shape, and they were
aligned side by side in a loosely arranged monolayered
epithelium (Fig. 2, D12A). Mitoses were commonly observed
at the apical face of colonies (Fig. 2, D12A). Some cells carried
microvilli and were tethered to their neighbors by tight
junctions, adherens junctions and gap junctions (Fig. 2,
D12B–C). These cells rested on a basement membrane, under
which a few solitary cells were sporadically distributed (Fig. 2,
D12A). Other cells were in close apposition, but not yet in
junctional contact with their neighbors, or with the basement
membrane (Fig. 2, D12D). In general, the cells contained large
nuclei with prominent nucleoli, and the cytoplasm was
dominated by mitochondria, free polyribosomes and vacuoles
(Fig. 2, D12D–E). Curiously, annular gap junctions were found
in some cells on both D12 and D18 (Fig. 2, D12E). On D18, the
colonies had matured into a well-structured sheet-like
columnar epithelium with a continuous apical surface covered
by microvilli and sealed by tight junctions, adherens junctions
and desmosomes (Fig. 2, D18A–C). Besides free polyribosomes,
the cells contained primarily mitochondria and lysosomes
(Fig. 2, D18D–E).
In summary, the ultrastructural characterization of
episomal reprogramming demonstrates that human fibro-
blasts retain most of their mesenchymal characteristics up
until D6 of reprogramming, and that they appear to initiate
an epithelial transition between days 6 and 12. Days 12 to 18
presumably involve maturation of the epithelial phenotype.
The MET associated with iPSC reprogramming shares
ultrastructural similarities with the EMT occurring
during mammalian gastrulation
Since human iPS cells are classified as “primed” or
“epiblast-like”, we were curious to see if we could spot any
resemblance between the development of iPSCs in vitro, and
the development of the mammalian epiblast in vivo. In other
words, we were interested in analyzing whether the MET
occurring during iPSC reprogramming would resemble a
rewinding of the morphological changes associated with EMT
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at gastrulation. Hence, we analyzed different stages of the
porcine gastrulation by TEM, aiming at identifying parallels to
the ultrastructural features presented for iPSC reprogramming
above. In longitudinal sections placed through the primitive
streak of porcine embryos at day 12, the epiblast was
characterized by a pseudostratified columnar epithelium with
microvilli covering the apical surface, and cells linked by
prominent tight junctions, intermediate junctions and desmo-
somes. On the basal side, epiblast cells were resting on a
basement membrane beneath which loose mesendodermal
progenitor cells were located. Underneath these, the hypoblast
was found (Fig. 2, lower panel). This stage of the porcine
Figure 1 Human fibroblasts form iPSC colonies around day 12 of episomal reprogramming. (A) On day 0 (D0) NHDFs were
electroporated with episomal plasmids and cultured on 0.1% gelatin in fibroblast medium (DMEM-AQ). After six days (D6), cells were
trypsinized and transferred to stem cell culture conditions consisting of BD Matrigel and mTeSR1. Approximately two weeks later
(D20–24), colonies were manually picked and expanded. Scale bar: 100 μm. (B) NHDFs were fixed with 6 day intervals during
episomal reprogramming and processed for scanning electron microscopy. NC: nucleoli, ER: endoplasmatic reticulum, LP:
lamellipodia, FP: filopodia, MV: microvilli, C: cilia, *: Cells with few or no microvilli. N = 3 for each time point. Scale bars in left
column: 100 μm, scale bars in middle column: 25 μm, and scale bars in right column: 10 μm.
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gastrulation roughly corresponds to the early trilaminar period
of the human embryo (at the end of the second week) (Gasser,
1975). As epithelial cells from the porcine epiblast ingress
through the primitive streak and breach the basement
membrane to become mesendodermal progenitors, they
transform from a columnar, polarized and tightly adhering
phenotype, like that of mature iPSCs, into dissociated and
solitary cells with migratory protrusions, comparable to cells at
D6–9 of reprogramming. Thus, the ultrastructural changes
associated with MET during reprogramming resemble a rewind-
ing of the changes seen at EMT during gastrulation.
Episomal reprogramming of human fibroblasts can
be divided into phases
To correlate the morphological observations with expression
patterns of MET and pluripotency markers, immunocyto-
chemistry and qPCR were performed on cells with six day
intervals during reprogramming (Fig. 3). Table S1 provides
an overview of the different markers, whose expression was
analyzed.
Phalloidin staining of F-Actin revealed that cytoskeletal
rearrangements could be detected as early as D6, when Actin
changed distribution from stress fibers to a more cortical
localization in a subpopulation of smaller cells. At D12, Actin
was lining the plasma membrane of iPSC-like cells and had
completely disappeared from the cytoplasm, giving the
colonies a cobblestone-like appearance, which was preserved
on D18 (Fig. 3A). The subcellular distribution of Beta-catenin
mimicked that of Actin, transitioning from the cytoplasm
towards the plasma membrane during reprogramming, pre-
sumably in order to form adherens junctions between cells of
developing iPSC colonies (Fig. 3A). Staining for the epithelial
marker E-cadherin confirmed the establishment of adherens
junctions at D12, whereas a weak Occludin signal indicated
the initial formation of tight junctions around this time point
(Fig. 3A). Onset of epithelial marker expression occurred
simultaneously with expression of the pluripotency marker
Nanog, and synchronized with a dramatic downregulation of
the mesenchymal marker, Vimentin (Fig. 3A). Thus, immuno-
cytochemistry confirmed an Initiation phase between D0 and
D12, where cells 1) decreased in size and rearranged their
Actin cytoskeleton (D0–D6); 2) lost their mesenchymal
characteristics and initiated the formation of epithelial
junctions (D6–12), 3) activated their endogenous pluripotency
apparatus (D6–12); followed by a Maturation phase from D12
and onwards during which colonies became fully epithelial and
increased in size.
In order to verify a correlation between the onset of an
epithelial expression program and the acquisition of plurip-
otent characteristics, quantification of colony numbers was
performed using multiple combinations of antibodies on
reprogramming cells on D12 and D18 post-electroporation
(Table 1 and supplementary Fig. S1). All E-cadherin positive
colonies displayed a cobble-stone-like web of Actin on both
D12 and D18 (100% of 43 and 57 colonies, respectively) as
was the case for Betacatenin (98% and 100% of 66 and 78
colonies, respectively), thus confirming the emergence of
adherens junctions on D12. Expression of E-cadherin also
Table 1 Quantification of iPSC-like colonies undergoing MET during reprogramming.
NHDFs were fixed on D12 and D18 of reprogramming and processed for double immunofluorescent labeling of E-cadherin with
Actin, Beta-catenin, Occludin, Vimentin, SSEA3 and TRA-1-60. For each combination of antibodies, the number of single or double
positive colonies was counted on D12 and D18 and given as a percentage of the total number of colonies. N denotes the number of
reprogrammings which the countings are based on. Representative images of the stainings are presented in Supplementary Fig. S1.
D12 D18
Marker combination % Colonies N % Colonies N
E-cadherin+/cortical Actin 100 43 3 100 57 3
E-cadherin+/cytoplasmic Actin 0 0
E-cadherin−/cortical Actin 0 0
E-cadherin+/cortical Beta-catenin 98 66 3 100 78 3
E-cadherin+/cytoplasmic Beta-catenin 0 0
E-cadherin−/cortical Beta-catenin 1 0
E-cadherin+/Occludin+ 100 16 1 98 55 3
E-cadherin+/Occludin− 0 2
E-cadherin−/Occludin+ 0 0
E-cadherin+/Vimentin+ 0 14 1 0 30 1
E-cadherin+/Vimentin− 100 100
E-cadherin−/Vimentin− 0 0
E-cadherin+/TRA-1-60+ 86 22 2 71 35 2
E-cadherin+/TRA-1-60− 14 26
E-cadherin−/TRA-1-60+ 0 3
E-cadherin+/SSEA3+ (63) 24 2 86 43 3
E-cadherin+/SSEA3− 37 14
E-cadherin−/SSEA3+ 0 0
Colony size 89 ± 37 μm 111 6 180 ± 105 μm 136 6
Average number of colonies on D18 per 104 fibroblasts: 21.85 ± 6.77 (n = 15).
Reprogramming efficiency based on number of colonies per 104 fibroblasts: 0.21%.
For each double immunofluorescent labeling, the most prevalent marker combination is emphasized in bold.
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Figure 2 Human iPSCs acquire an epiblast-like morphology between days 12 and 18 of episomal reprogramming. NHDFs were fixed
on days 0, 6, 9, 12 and 18 during reprogramming and processed for transmission electron microscopy. Images from D6 are based on
horizontal sections (h.s.) All other images are from transverse sections. The porcine embryo was fixed around days 12–13 of gestation
and sectioned vertically through the primitive streak. RER: rough endoplasmatic reticulum, IF: intermediate filaments, N: nucleolus,
G: golgi, M: mitochondria, MI: mitosis, BM: basement membrane, TJ: tight junction, AJ: adherens junction, GJ: gap junction, AGJ:
annular gap junction, D: desmosome, L: lysosome, EPI: epiblast, EMT: Epithelial–Mesenchymal Transition, MES: mesendoderm, HY:
hypoblast. N = 2–5 for each time point.
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positively correlated with expression of the tight junction
marker Occludin on both D12 and D18 (100% and 98% of 16
and 55 colonies, respectively). There was a negative
correlation between expression of E-cadherin and Vimentin
in iPSC-like colonies on both D12 and D18 (100% of 14
colonies on D12, 100% of 38 colonies on D18) with all
E-cadherin positive colonies showing the absence of
Vimentin. Overall, this confirms that the upregulation of
epithelial markers during reprogramming was coordinated
with the downregulation of mesenchymal markers within the
same colonies. The majority of E-cadherin positive colonies
were also positive for the pluripotency marker TRA-1-60 on
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D12 and D18, signaling a positive correlation between the
acquisition of epithelial and pluripotent characteristics (86%
of 22 colonies on D12, 71% of 35 colonies on D18). However,
only 63% of the E-cadherin positive colonies expressed the
pluripotency marker SSEA3 on D12, and the expression was
weak and heterogeneous in contrast to D18, when 86% of 43
E-cadherin positive colonies were clearly SSEA3 positive.
This indicates that SSEA3 may be upregulated later than
E-cadherin. Overall, the results suggest that the expression
of epithelial markers and pluripotency markers occurs in an
orchestrated fashion within the forming iPSC colonies
between D12 and D18 of reprogramming.
It has been reported that knockdown of the tumor
suppressor gene P53 can enhance reprogramming of MEFs
to iPSC by accelerating MET (Brosh et al., 2013). In order to
investigate whether the short hairpin targeting P53 in our
reprogramming cocktail was altering the dynamics of MET
we performed immunostainings of human fibroblasts under-
going reprogramming in the presence or absence of the
hairpin. As shown in Fig. 3B, the coordinated expression of
E-cadherin and Nanog with repression of Vimentin in
transfected cells took place between D6 and D12, irrespec-
tive of P53 status (Hoechst overlays are displayed in Fig. S2).
However, as was recently published by our group (Rasmussen
et al., 2014), colonies were generally larger and more
numerous when P53 was inhibited (Fig. 3B).
On the transcriptional level, the relative expression of
mesenchymal markers VIM, ZEB1 and SLUG appeared
constant or slightly downregulated throughout the first
18 days of reprogramming (Fig. 3C), in contrast to the
dramatic reduction of all three markers in iPSC colonies at
passage 3. This probably reflects the large number of
non-reprogrammed fibroblasts in the samples from all time
points prior to passage on day 20 (Fig. 1A). On the other
hand, transcription of the epithelial markers CDH1, OCLN
and EPCAM was dramatically increased from D12 and
onwards, supporting the hypothesis that the MET initiates
before D12 of reprogramming (Fig. 3C). Surprisingly, the
transcription of CDH1 was downregulated between D0 and
D6, thus challenging the assumption that fibroblasts are
most mesenchymal-like at day 0 of reprogramming. Howev-
er, expression of the tight junction gene OCLN was
upregulated in this period, suggesting that on D6, mesen-
chymal cells were starting to tune in on an epithelial
transition already at this early time point. The relative
expression of early pluripotency markers Nanog, UTF1 and
DPPA2 was increased to 100 fold at D12 of reprogramming,
and remained at a stable, high level during the remaining
reprogramming period (Fig. 3C). Overall, the qPCR data
indicated that the transcriptional activation of a MET
program initiated between D0 and D12, and synchronized
with onset of endogenous pluripotency.
Beta-catenin displays a dynamic subcellular
distribution in cells undergoing reprogramming
As previously mentioned, Beta-catenin appeared to follow the
distribution of Actin during reprogramming, transitioning from
the cytoplasm of fibroblasts towards the plasmamembranes of
iPSCs. However, when looking closer at Beta-catenin localiza-
tion in transfected cells co-immunostained for Oct4, we
realized that on D6, Beta-catenin could be found in three
different compartments in different cells (Fig. 4). In aminority
of Oct4 positive cells, Beta-catenin was localized to the
cytoplasm as on D0 of reprogramming (Fig. 4, D6A), whereas in
the majority of transfected cells, there was a strong nuclear
Beta-catenin signal on D6 (Fig. 4, D6B). Some cells with
nuclear Beta-catenin signal also displayed a cortical distribu-
tion of Beta-catenin (Fig. 4, D6C), as shown on D12 and D18
(Fig. 3A). The cytoplasmic Beta-catenin signal was observed
only in solitary and stellate fibroblast-like cells with promi-
nent stress fibers, in contrast to the nuclear signal, which was
associated with cells that had decreased in size and retracted
their migratory protrusions. Cells displaying both nuclear and
plasma membrane-associated localization of Beta-catenin on
D6 were tightly associated with each other in small clusters,
and they looked like daughter cells at the earliest stage of
colony formation. These preliminary data may indicate that
during reprogramming, Beta-catenin translocates from the
cytoplasm into the nucleus before finally attending to the
formation of adherens junctions at the plasma membranes of
early iPSCs.
Live-cell imaging supports a MET between days 6
and 12 of reprogramming
Live cell imaging was performed to visualize the MET
real-time during iPSC reprogramming. For this purpose,
human fibroblasts containing a Vimentin promoter-GFP
construct were electroporated with episomal plasmids, and
their growth and behavior were monitored from D6 to D15
post-electroporation (Supplementary movie S1). Fig. 5A
depicts a series of 24 hour interval snapshots of a
Figure 3 The MET is synchronized with the acquisition of pluripotent traits and occurs regardless of P53 status. (A) NHDFs were
fixed with 6 day intervals during reprogramming and processed for double immunofluorescent labeling of: Beta-catenin/Actin to
visualize changes in cytoskeletal arrangement; Vimentin/E-cadherin to visualize MET, and Occludin/Nanog to visualize a coordinated
upregulation of epithelial and pluripotency markers. All images were acquired at the same magnification and are presented as
overlays with Hoechst nuclear staining (blue). Scale bars: 50 μm. (B) NHDFs were fixed on days 6 and 12 of reprogramming with or
without a short hairpin targeting P53, and processed for double immunofluorescent labeling of Oct4 with E-cadherin, Vimentin, Nanog
or SSEA4. All images were acquired at the same magnification and are presented as overlays. Scale bar: 50 μm. (C) Cells from three
independent experiments were processed for qPCR with 6 day interval during reprogramming, and after three passages (P3). Samples
were measured in triplicate, and the mean values + standard deviations are shown for each of the indicated genes. All values are
relative to day 0 and normalized to ACTB. Please note that the graphs have different log scales. *: P N 0.05, **: P b 0.01, ***:
P b 0.001, ****: P b 0.0001.
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reprogramming event, in which GFP-positive fibroblasts
(encircled in red) give rise to a GFP-negative iPSC colony.
The recording shows how two GFP positive cells cluster
together and migrate as one compact unit at D6, after which
the cells settle down and start dividing. Between D6 and
D12, the cells in the cluster vary in size and shape, and they
seem to divide and move around each other while remaining
closely associated. On D11, the GFP signal in the colony
begins to fade, and after 24 h it is barely detectable,
supporting previous indications of Vimentin expression
ceasing around D12 of reprogramming, when epithelial and
pluripotent features initially develop. From D12 onwards,
the cells and their offspring remain GFP-negative, and as
they develop into a colony, they become more uniform in
size. Please note that the GFP signal of fibroblasts at D6
varied among cells, as the transfected cell population was
not clonal. Therefore, rather than identifying GFP negative
cells as an evidence of MET, we were tracking only cells that
were initially GFP positive. Fig. 5B displays immunostainings
of the colony after 9 passages to verify the pluripotent state
of the tracked cells. Fig. 5C displays Vimentin promoter-GFP
fibroblasts which were FACS sorted prior to reprogramming
to ensure that the starting population displayed a
homogenous, strong GFP signal. Reprogramming of this cell
line was less efficient but nevertheless produced GFP
negative colonies which were positive for Nanog, TRA-1-60
and E-cadherin on D12, and which could be passaged to NP7,
thus confirming MET as a gateway for fibroblasts on the road
to pluripotency.
In summary, we found that our reprogramming process
from D0 to D18 involves a sequence of events which can be
divided into an Initiation phase (D0–12) and a Maturation
phase (D12–18) according to the nomenclature suggested by
Samavarchi-Tehrani et al. (2010) (Fig. 6). During the first six
days of the Initiation phase, cells are predominantly
mesenchymal, but decrease in size and start to rearrange
their Actin cytoskeleton. In this period, transcription of
some epithelial and pluripotency markers appears to
initiate, but on the translational and morphological level,
these markers are not yet apparent. Between days 6 and 12
of the Initiation phase, cells replace their mesenchymal
characteristics with epithelial and pluripotent features, in a
process bearing inverse resemblance to the dynamics of the
EMT occurring during mammalian gastrulation in vivo. The
Maturation phase between days 12 and 18 involves expansion
of the newly acquired epithelial and pluripotent phenotype.
Figure 4 Beta-catenin translocates between cytoplasm, nucleus and plasma membrane during reprogramming. NHDFs were fixed
with 6 day intervals during reprogramming and processed for double immunofluorescent labeling of Beta-catenin and Oct4 to
visualize the localization of Beta-catenin in transfected cells. Here, three different cell phenotypes from day 6 are shown (D6A, D6B,
D6C). All images were acquired at the same magnification. Scale bar: 50 μm.
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Discussion
The study of human embryonic development is challenged by
ethical concerns associated with the use of in vitro fertilized
donor material, or abortions, and by the limited access to such
sample material. Consequently, the ultrastructural informa-
tion about human epiblasts at the post-implantation stage is
primarily based on findings from other species such as other
primates, pigs and rodents (reviewed in (Pera and Trounson,
2004)). Here, we analyzed porcine gastrulation by TEM in
order to decipher whether the MET occurring on the road to
induced pluripotencymimics a reversal of the EMTwhich takes
place during gastrulation in vivo. Wewere able to demonstrate
that the artificial rewinding of differentiated human cells to
induced pluripotency results in a cellular phenotype which
resembles the human epiblast 7–12 days post-fertilization
(Gasser, 1975; Hertig and Rock, 1945, 1949a, 1949b, 1949b).
In this regard, one may speculate that the apical-to-basal
Figure 5 Live cell imaging confirms a MET around day 12 of reprogramming. (A) NHDFs carrying a Vimentin promoter-GFP reporter
construct were monitored in a Biostation between days 6 and 15 of reprogramming. Phase contrast, epifluorescence and merged images
are presented from left to right with 24 hour interval. The red ring marks tracking of cells which produce a Vimentin-negative colony. All
images were acquired at the same magnification. Scale bars: 50 μm. (B) The tracked colony was passaged and expressed cortical
Beta-catenin and E-cadherin as well as the pluripotency markers Nanog, Oct4 and SSEA3 at P9. All images were acquired at the same
magnification. Scale bar: 50 μm. (C) FACS enriched Vimentin promoter-GFP NHDFs were fixed on D12 post-electroporation and labeled
with Nanog, TRA-1-60 and E-cadherin to verify that MET occurs around D12 in reprogramming fibroblasts. Scale bars: 50 μm.
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migration of gastrulating epiblast cells during EMT is recapitu-
lated in reverse order in iPSC colonies around day 12, when
sporadically distributed mesenchymal-like cells underlying the
early forming iPSC epithelium appear to move in the basal–
apical direction up through the discontinuous basement
membrane to become integrated as epithelial cells into the
forming colony (Fig. 2, D12). The hypothesis that fibroblasts
dedifferentiate to iPSC in a process which bears resemblance to
a reverse gastrulation was recently supported by a publication
from the Yamanaka group (Takahashi et al., 2014). They
showed that TRA-1-60 positive human cells undergoing
reprogramming to iPSC had a transient gene expression profile
reminiscent of primitive streak mesendoderm, and that
overexpression of the transcription factor forkhead box H1
(FOXH1), which is crucial for the specification of the primitive
streak, enhanced MET and the formation of iPSC (Takahashi et
al., 2014). It would be interesting to visualize the morphogen-
esis of reprogramming cells which display this transient
mesendodermal gene expression, in order to establish whether
they resemble mesendodermal progenitors in the primitive
streak on the morphological level. In present study, we were
primarily analyzing cells in earlier stages of reprogramming
Figure 6 Overview of morphological changes and gene expression dynamics during episomal reprogramming of human fibroblasts to
iPSC. Abbreviations: TJ: tight junctions, AJ: adherens junctions, GJ: gap junctions, BM: basement membrane, E.R.: endoplasmatic
reticulum.
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between D0 and D12, when no pluripotency markers were yet
expressed, hence we cannot exclude the possibility that our
ultrastructural characterizations were performed on partially
reprogrammed cells. The correlation between acquisition of
epithelial and pluripotent characteristics shown in Table 1
suggests that the epithelial iPSC-like colonies presented in Fig. 2
(D12, D18) were indeed destined to become true iPSCs.
However, in order to fully confirm this, correlative light and
electron microscopical analyses of TRA-1-60 positive cells
undergoing reprogramming from D12 and throughout the
maturation period would be needed.
Gene expression studies of partially or fully reprogrammed
MEFs have led several groups to define distinct stages of
reprogramming, as elegantly reviewed by David and Polo
(2014). Generally, three phases are proposed; the first one
being defined by MET, increased proliferation and cytoskeletal
rearrangements (Li et al., 2010; Samavarchi-Tehrani et al.,
2010; Sakurai et al., 2014; Mikkelsen et al., 2008; Sridharan et
al., 2009; Stadtfeld et al., 2008; Polo et al., 2012; Hansson et
al., 2012), the second comprising an intermediate or partial
stage of reprogramming during which early pluripotency
markers are upregulated (SSEA1 in mouse, TRA-1-60 in
human, followed by Nanog and Oct4) (Sridharan et al., 2009;
Stadtfeld et al., 2008; Polo et al., 2012; Hansson et al., 2012;
Brambrink et al., 2008; Tanabe et al., 2013), and finally the
third phase when passaged pluripotent colonies exhibit
transgene independence, X-reactivation and telomere elon-
gation (Mikkelsen et al., 2008; Sridharan et al., 2009;
Stadtfeld et al., 2008; Brambrink et al., 2008). As previously
mentioned, these three phases were named Initiation,
Maturation and Stabilization by J. Wrana and group in 2010
(Samavarchi-Tehrani et al., 2010.
All of these studies categorize MET as an initial event
during reprogramming which is followed by upregulation of
the pluripotency machinery later in the process. Here we
observed that in the time course of reprogramming human
fibroblasts to iPSCs, the MET was preceded by a six day
period (D0–6), during which cells decreased in size,
rearranged their Actin cytoskeleton and retained a partly
mesenchymal phenotype. Epithelial characteristics such as
adherens junctions and tight junctions were not established
before D12 when the pluripotency markers TRA-1-60, Nanog,
UTF1 and DPPA2 were upregulated, thus suggesting a
synchronized acquisition of epithelial and pluripotent traits.
We speculated whether this could be due to the fibroblast
culture conditions during the first six days of our reprogramming
protocol, which could potentially delay MET. However no
colonies emerged when we cultured our reprogramming cells
in stem cell conditions from day 1 post-electroporation. Thus,
we propose that the discrepancy in the timing of MET may be
a matter of species-related differences in reprogramming
dynamics, given that most of aforementioned studies were
performed with MEFs. This is supported by three other studies
of human fibroblasts undergoing reprogramming to iPSCs,
which reported E-cadherin expression beginning between days
6 and 15 of reprogramming (Onder et al., 2012; Subramanyam
et al., 2011b) and TRA-1-60 positive hiPSC colonies emerging
between days 11 and 15 of reprogramming (Takahashi et al.,
2014).
It was recently shown that promoting a brief mesenchy-
mal phase prior to the MET could enhance the formation of
both mouse and human iPSC colonies (Liu et al., 2013; Di et
al., 2014). The hypothesis that mesenchymal cells must
undergo an EMT-like reinforcement before turning their fate
towards becoming a pluripotent epithelium correlates with
our preliminary observations of Beta-catenin accumulating
in the nucleus during the Initiation phase of reprogramming.
Nuclear translocation of Beta-catenin is a hallmark of
Canonical Wnt signaling and EMT, whereas recruitment of
Beta-catenin to the plasma membrane indicates the forma-
tion of epithelial adherens junctions and MET (Zeisberg and
Neilson, 2009; Kam and Quaranta, 2009). Thus, the pre-
sumed movement of Beta-catenin from the cytoplasm to the
nucleus between days 0 and 6 in our reprogramming
experiments, and from the nucleus to the plasma membrane
between days 6 and 12, supports the sequential EMT–MET
dynamics reported in Liu et al. (2013).
Conclusion
Here, we provide the first combined ultrastructural, immuno-
cytochemical and gene expression analysis of human fibro-
blasts at various stages of episomal iPSC reprogramming, as
well as the first real-time live cell visualization of MET during
reprogramming. Our results indicate that the MET occurs
approximately 6–12 days after electroporation in synchrony
with the upregulation of pluripotency markers, and resembles
a reversal of the EMT which takes place during mammalian
gastrulation.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.11.003.
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